Las empresas participadas por capital riesgo crecen más rápido y crecen mejor, se sitúan en la cabecera en cuanto a creación de lugares de trabajo cualificados e innovación y son más eficientes ...
Read more
Ysios Capital, a European life sciences venture capital firm, today announced that it has appointed Wen Wen Cheng as Head of Legal.
Read more
DeepUll, a medical diagnostics company developing culture-free, affordable diagnostic solutions for the early identification of sepsis and other acute infections, announces today that it has raised
Read more
SpliceBio, compañía biotecnológica de terapia génica con sede en Barcelona basada en tecnología desarrollada en la Universidad de Princeton, ha recibido el galardón a la “Ronda de Inversión S...
Read more
The Investor Deck can be described as the business card of a entrepreneurship project where through an executive presentation, thus summarized, of between 10-15 slides the investor can obtain the esse...
Read more
This is the first investment forum organized in Spain by a public hospital. During the event, the different financing models were explored and crowdfunding for startups, and the spin-offs of Parc Taul...
Read more
En los últimos dos años hemos vivido una transformación en la industria sanitaria, viendo como dos grandes industrias, independientes y en constante evolución, se acercaban hasta acabar convergien...
Read more
GENESIS Biomed, a consultancy firm that specialises in early-stage R&D projects in the biomedical sector, expects to close out 2022 with record turnover of €1.6 million, up 28% from the previous yea...
Read more
La biotecnológica española Neurofix Pharma ha puesto la primera piedra para desarrollar los dos últimos hitos clínicos previos a lograr un producto comercializable. La compañía acaba de firmar l...
Read more
The incubator, whose goal is to transfer knowledge and apply its clinical and research and development capabilities to the market through startups, is working on the feasibility of 8 new projects.
Read more
Asabys has announced the 1st closing of its 2nd fund, with commitments of €100 million. The firm’s goal is to reach €200 million this year, to invest in 12 to 15 companies in the EU, Israel, UK ...
Read more
This article with the most representative slides to start the roadshow, will allow us to face with guarantees the success of the journey we will undertake in the negotiation of our investment round wi...
Read more
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
En nuestro post hablamos sobre este interesante tipo de célula del...
Research led by IIBB-CSIC and CIBEREHD scientists identifies S-adenosy...
